Latest Insider Transactions at Gritstone Bio, Inc. (GRTS)
This section provides a real-time view of insider transactions for Gritstone Bio, Inc. (GRTS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Gritstone bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Gritstone bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 20
2021
|
Raphael Rousseau Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.76 P/Share
|
Jan 19
2021
|
Roman Yelensky Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.98%
|
$220,000
$22.1 P/Share
|
Jan 19
2021
|
Raphael Rousseau Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$340,000
$17.53 P/Share
|
Jan 19
2021
|
Raphael Rousseau Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$0
$0.76 P/Share
|
Jan 07
2021
|
Andrew R Allen PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,200
+50.0%
|
-
|
Jan 07
2021
|
Matthew Hawryluk EVP, CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
19,600
+44.75%
|
-
|
Jan 07
2021
|
Karin Jooss |
BUY
Grant, award, or other acquisition
|
Direct |
27,900
+7.39%
|
-
|
Jan 07
2021
|
Rahsaan Thompson EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+46.37%
|
-
|
Jan 07
2021
|
Roman Yelensky Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,400
+13.84%
|
-
|
Jan 07
2021
|
Raphael Rousseau Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,700
+50.0%
|
-
|
Jan 07
2021
|
Vijay Yabannavar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+46.9%
|
-
|
Jan 07
2021
|
Erin Jones EVP, CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,900
+36.07%
|
-
|
Dec 30
2020
|
Thomas Woiwode Director |
BUY
Open market or private purchase
|
Indirect |
1,347,709
+50.0%
|
$4,043,127
$3.71 P/Share
|
Oct 02
2018
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,394,529
+27.65%
|
-
|